Emcure Pharma IPO: Emcure Pharmaceuticals Gives Sebis The Green Light For The IPO

Emcure Pharmaceuticals, which is backed by Bain Capital, has received the green light from capital markets regulator Sebi to raise funds through an initial stock sale. The initial public offering (IPO) includes the re-issuance of shares valued at Rs.1,100 billion and the OFS of 18,168,356 shares by promoters and existing shareholders under the Red Hering Prospectus (DRHP) draft.

As part of the OFS, the promoters will – Satish Mehta will sell 20.30 lakh shares, Sunil Mehta will sell 2.5 lakh shares – and the investor BC Investments IV Ltd will sell 99.5 lakh shares among others.

Leave a Reply

Your email address will not be published.